The Italian Competition Authority (AGCM) has launched a formal investigation into beauty giants Benefit and Sephora, both LVMH subsidiaries. The inquiry centers on allegations that these brands exploit young influencers to market adult skincare—specifically face masks, serums, and anti-aging creams—to children under 10, encouraging compulsive purchases among pre-adolescent consumers, as reported by BBC. This aggressive marketing, often framed as 'self-care,' ignites urgent ethical questions about children's skincare in 2026.
Beauty brands aggressively market adult skincare as 'self-care' to children, yet this practice is causing documented physical harm and fostering serious psychological issues. This contradiction exposes a disturbing trend: major beauty companies are blurring ethical lines to aggressively expand their market into vulnerable young consumers.
Given these growing medical concerns and escalating regulatory action, it appears likely that more countries will follow Italy's lead, cracking down on beauty brands that exploit children's vulnerabilities for profit.
The Physical Toll of Premature Skincare
Associate Professor Giovanni Damiani observed a sharp rise in irritant and allergic contact dermatitis among eight- to 14-year-old patients. These adverse reactions stemmed directly from the unsupervised use of chemical exfoliants and retinoids, products typically requiring adult discretion or prescriptions, as reported by The Guardian. Concurrently, the AGCM's investigation suggests companies deliberately failed to indicate these cosmetics were unsuitable for children, instead employing covert marketing to drive sales, according to En Agcm It. This confluence of medical harm and deceptive promotion reveals a disturbing pattern of prioritizing profit over pediatric health.
The products under scrutiny—face masks, serums, and anti-aging creams—were often marketed with an apparent focus on girls under 10. This direct link between deceptive marketing and documented medical issues is not merely a failure of corporate responsibility; it's a calculated disregard for child safety, where sales targets supersede the well-being of minors.
Exploiting Childhood Insecurities
More than 50% of young people report unhappiness with their appearance, with up to 90% expressing some level of concern, according to The Guardian. This pervasive dissatisfaction creates a fertile, and ethically fraught, ground for beauty brands to exploit.
Sephora and Benefit are not simply reacting to existing market demand; they are actively manufacturing it. By marketing anti-aging creams to children under 10, as the AGCM investigation reveals, these brands cultivate a generation taught to fear aging before puberty. This strategy positions unnecessary products as solutions to fabricated insecurities, fundamentally undermining the concept of genuine self-care.
The Rise of Cosmeticorexia
Italian researchers have published a paper proposing cosmeticorexia as a clinically relevant mental disorder, as reported by The Guardian. This emerging condition describes an obsession with 'flawless skin,' driving compulsive purchasing and use of cosmetics. Significantly, Italian authorities explicitly cited cosmeticorexia as a primary concern in their crackdown on beauty brands allegedly targeting younger shoppers. This recognition by regulators elevates the issue beyond mere consumer trend to a public health concern.
The emergence of cosmeticorexia, a potentially clinically relevant mental disorder directly linked to children's compulsive purchase of adult cosmetics, starkly reveals beauty brands trading the long-term mental and physical health of minors for short-term profits. Regulators are only now beginning to grasp this profound trade-off, which signifies the lasting psychological damage stemming from early exposure to intense beauty pressures.
A Call for Broader Accountability
The marketing strategy under investigation allegedly leveraged 'very young micro-influencers' to actively encourage compulsive cosmetic purchases among their peers, as reported by The Guardian. This calculated targeting of impressionable youth, bypassing parental oversight and medical guidance, exposes a systemic failure of industry ethics. The convergence of documented physical harm, the emergence of cosmeticorexia, and such deliberate marketing tactics demands immediate and broader regulatory scrutiny. Consequently, by the end of 2026, other European nations will likely introduce similar regulatory actions, potentially reshaping how global beauty brands like Benefit and Sephora engage with their youngest demographic.
